Josef Finsterer received his M.D. and Prof. of Neurology from the University of Vienna, Austria. Since his training as a clinical neurologist and electrophysiologist at the Neurological Krankenhaus Rosenhuegel and the Ludwig Boltzmann Institute for Epilepsy and Neuromuscular Disorders he is involved in the management of neuromuscular disorders, particularly muscular dystrophies and metabolic myopathies. In addition to neuromuscular disorders, research interests focus on genetics, orphan diseases, and cardiac involvement in genetic conditions.
"... The patient is a 29-year-old ... female, who was hospitalised at a primary care unit for acute onset vertigo and dysarthria ... 4 days prior to the cerebrovascular event, she had undergone a first vaccination with a vector-based SARS-CoV-2 vaccine ... There was no indication for deep venous thrombosis. Cerebral MRI 19 days after the stroke confirmed the previously detected ischaemic lesion in the right cerebellar hemisphere ...
[T]his case shows that juvenile, ischaemic stroke may occur shortly after vaccination with a vector-based SARS-CoV-2 vaccine in a patient with the risk factors smoking and PFO [patent foramen ovale]."
Letter to Editor
Copyright: © 2022 Journal of Family Medicine and Primary Care
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.